Arkolith/Insider Trading/CARA/Form 4

Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.Cara Therapeutics, Inc. (CARA) · full profile →Form 4 · filed Mar 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$776
Net Open-Market Flow
-$776
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 28, 2025Sell(S)163$4.76$7767K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-006575) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML